Profile data is unavailable for this security.
About the company
Shanghai MicroPort Endovascular MedTech Group Co Ltd, formerly Shanghai MicroPort Endovascular MedTech Co Ltd, is a China-based company principally engaged in the research and development, production and sales of aortic and peripheral vascular interventional medical devices. The Company's main products include the aortic stent graft system for aortic minimally invasive interventional procedures, the intraoperative stent system for open surgery, as well as the peripheral vascular stent system and peripheral balloon dilatation catheters for the treatment of peripheral vascular diseases. The Company mainly distributes its products to the domestic market.
- Revenue in CNY (TTM)1.27bn
- Net income in CNY657.34m
- Incorporated2012
- Employees908.00
- LocationShanghai MicroPort Endovascular MedTech Group Co LtdNo. 1, Lane 3399, Kangxin HighwayPudong New AreaSHANGHAI 201318ChinaCHN
- Phone+86 2 138139300
- Fax+86 2 133750026
- Websitehttps://www.endovastec.com/
More ▼
Mergers & acquisitions
| Acquired company | 688016:SHH since announced | Transaction value |
|---|---|---|
| Optimum Medical Ltd | -17.47% | 65.00m |
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shenzhen YHLO Biotech Co Ltd | 1.90bn | 288.64m | 10.89bn | 1.76k | 38.00 | 4.10 | -- | 5.73 | 0.5026 | 0.5026 | 3.32 | 4.66 | 0.4842 | 1.07 | 4.58 | 1,081,307.00 | 5.85 | 16.43 | 7.46 | 24.16 | 63.98 | 53.26 | 12.08 | 20.01 | 1.28 | 9.13 | 0.2474 | 30.28 | -48.42 | 23.02 | -64.93 | 56.32 | 28.88 | -- |
| Shinva Medical Instrument Co Ltd | 10.12bn | 692.34m | 11.26bn | 8.21k | 13.13 | 1.50 | -- | 1.11 | 1.41 | 1.41 | 18.31 | 12.34 | 0.6775 | 2.20 | 4.96 | 1,232,589.00 | 4.72 | 4.63 | 9.14 | 10.76 | 25.62 | 24.22 | 6.96 | 6.12 | 0.8303 | -- | 0.1637 | 15.91 | 7.87 | -0.5342 | 30.78 | 95.70 | -5.90 | 61.86 |
| Qingdao Haier Biomedical Co Ltd | 2.24bn | 358.01m | 11.69bn | 2.64k | 32.63 | 2.72 | -- | 5.23 | 1.13 | 1.13 | 7.04 | 13.53 | 0.4018 | 5.12 | 6.38 | 848,473.70 | 6.56 | 11.49 | 8.29 | 15.22 | 47.82 | 49.98 | 16.34 | 25.20 | 2.53 | -- | 0.0316 | 26.53 | -20.36 | 22.07 | -32.41 | 28.94 | 20.64 | -- |
| Beijing Wandong Medical Technolgy Co Ltd | 1.40bn | 184.09m | 12.17bn | 1.06k | 66.07 | 2.57 | -- | 8.67 | 0.262 | 0.262 | 2.00 | 6.74 | 0.2647 | 2.76 | 4.01 | 1,325,746.00 | 3.50 | 5.30 | 3.91 | 6.21 | 38.83 | 45.21 | 13.22 | 16.46 | 9.48 | -- | 0.0179 | 35.82 | 10.30 | 5.32 | 7.51 | 4.22 | -16.66 | 5.39 |
| Shandong Weigao Orthopaedic Devce Co Ltd | 1.28bn | 154.60m | 12.19bn | 2.21k | 79.00 | 3.12 | -- | 9.49 | 0.3858 | 0.3858 | 3.20 | 9.78 | 0.2524 | 0.6714 | 4.03 | 581,131.60 | 3.14 | 10.97 | 3.95 | 13.69 | 62.40 | 77.33 | 12.43 | 27.08 | 3.62 | -- | 0.0096 | 17.90 | -30.55 | 1.17 | -79.36 | -19.11 | -4.31 | -- |
| Shanghai Runda Medical Technology Co Ltd | 8.43bn | 40.27m | 13.18bn | 3.32k | 326.80 | 3.07 | -- | 1.56 | 0.0673 | 0.0673 | 13.61 | 7.17 | 0.5831 | 4.19 | 1.49 | 2,543,990.00 | 1.18 | 4.78 | 3.13 | 12.86 | 25.94 | 27.13 | 2.03 | 6.36 | 1.01 | 3.04 | 0.5609 | 12.43 | -12.84 | 8.93 | -34.58 | 0.8514 | 3.88 | 1.03 |
| Shanghai MicroPort Edvcl MdTch Grp CoLtd | 1.27bn | 657.34m | 13.61bn | 908.00 | 20.30 | 3.50 | -- | 10.73 | 5.44 | 5.44 | 10.59 | 31.54 | 0.371 | 1.33 | 6.51 | 1,396,816.00 | 19.00 | 17.68 | 21.55 | 19.43 | 74.51 | 76.60 | 51.21 | 42.25 | 5.49 | -- | 0.0067 | 44.46 | 32.43 | 38.72 | 37.98 | 40.28 | 50.18 | -- |
| Sansure Biotech Inc | 1.41bn | 259.42m | 13.73bn | 2.01k | 52.67 | 1.87 | -- | 9.76 | 0.4475 | 0.4475 | 2.44 | 12.62 | 0.1667 | 0.878 | 2.03 | 701,473.70 | 2.52 | 26.74 | 2.79 | 30.97 | 76.43 | 67.47 | 15.12 | 42.01 | 7.45 | -- | 0.0583 | 22.40 | -84.39 | 27.12 | -81.22 | 121.89 | 64.08 | -- |
| Micro-Tech Nanjing Co Ltd | 2.68bn | 550.49m | 14.58bn | 2.40k | 26.40 | 3.91 | -- | 5.44 | 2.94 | 2.94 | 14.30 | 19.86 | 0.6118 | 1.65 | 6.80 | 1,114,222.00 | 12.87 | 10.74 | 15.26 | 12.82 | 66.04 | 63.04 | 21.04 | 19.37 | 3.99 | -- | 0.0183 | 35.43 | 21.78 | 21.20 | 46.99 | 20.32 | 39.33 | -- |
| Shanghai Haohai Biological Tech Co Ltd | 2.75bn | 430.21m | 14.89bn | 2.16k | 38.09 | 2.95 | -- | 5.42 | 1.86 | 1.86 | 11.89 | 24.07 | 0.3833 | 1.60 | 7.60 | 1,272,966.00 | 5.60 | 4.84 | 6.60 | 5.50 | 68.97 | 72.04 | 14.61 | 16.36 | 3.71 | -- | 0.0697 | 36.86 | 24.59 | 11.24 | 130.58 | 0.0762 | 11.96 | -- |
Data as of Sep 13 2024. Currency figures normalised to Shanghai MicroPort Endovascular MedTech Group Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
14.06%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nuode Asset Management Co., Ltd.as of 24 Jun 2024 | 4.59m | 3.73% |
| Harvest Fund Management Co., Ltd.as of 24 Jun 2024 | 3.52m | 2.86% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 30 Jun 2024 | 2.31m | 1.88% |
| Caitong Fund Management Co., Ltd.as of 24 Jun 2024 | 2.27m | 1.85% |
| Hwabao WP Fund Management Co., Ltd.as of 30 Sep 2023 | 1.52m | 1.23% |
| E Fund Management Co., Ltd.as of 24 Jun 2024 | 752.39k | 0.61% |
| CITIC Securities Co., Ltd. (Invt Port)as of 24 Jun 2024 | 725.84k | 0.59% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2024 | 557.05k | 0.45% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2024 | 542.04k | 0.44% |
| China Asset Management Co., Ltd.as of 30 Jun 2024 | 528.27k | 0.43% |
More ▼
Data from 30 Jun 2024 - 29 Oct 2024Source: FactSet Research Systems Inc.
